SVP, General Counsel
Envista’s core values, which we refer to as CIRCLe, and our dedication to EBS principles provide a foundation for growth and notable quality in an environment where our team is proud to come to work each day.
Mark joined Envista in 2019 prior to its IPO. Previously he served as Chief Legal Officer for INSYS Therapeutics, Inc., where he teamed with management and the board to focus on its restructuring. He has nearly 20 years of experience serving in the role of General Counsel.
Mark has also held roles as General Counsel for Mylan, N.V., a global pharmaceutical company, and led the legal teams at G.E. Healthcare Medical Diagnostics and G.E. Healthcare Life Sciences. His government service includes time at the Office of Policy Planning at the U.S. Federal Trade Commission, as a commissioned officer in the U.S. Marine Corps, and for seven years as an original member of the National Science Advisory Board for Biosecurity.
Mark holds a BA in Political Science from the University of Missouri and a JD from Cornell Law School.